Chemocentryx (CCXI) Reports Q4 EPS of 61c, Revs Double
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts CCXI Hot Sheet
Join SI Premium – FREE
Chemocentryx (NASDAQ: CCXI) reported Q4 EPS of $0.61, versus $0.17 reported last year. Revenue for the quarter came in at $26.1 thousand, versus $13.1 million reported last year.
For earnings history and earnings-related data on Chemocentryx (CCXI) click here.
For earnings history and earnings-related data on Chemocentryx (CCXI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- Wells Fargo Names Top Pick Ahead of Q3 Earnings
- Dollar Tree shares drop amid analyst downgrade pressure
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
